4.7 Review

Safety assessment of β-nitropropionic acid:: a monograph in support of an acceptable daily intake in humans

Journal

FOOD CHEMISTRY
Volume 75, Issue 1, Pages 1-27

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S0308-8146(01)00194-7

Keywords

NPA; excitotoxicity; Huntington's disease; mitochondrial toxin

Ask authors/readers for more resources

Several molds, Aspergillus, Penicillium and to a lesser extent, Arthrinium can produce beta -nitropropionic acid (NPA). The presence of NPA has been detected in at least four families of higher plants. Use of Aspergillus as an economic mould in the production of foods and the accidental contamination of foods provides for an historically lengthy and widespread exposure of humans to NPA. Despite widespread consumption of foods containing NPA, human poisoning by NPA is rare and confined to circumstances involving gross mishandling of the food products. NPA is absorbed in the gastrointestinal tract, enters the circulation and is metabolized to nitrite, although some may bind succinate dehydrogenase upon oxidation, The primary mechanism of toxicity of NPA is as a suicide substrate (non-competitive inhibitor) of succinate dehydrogenase, an enzyme of the mitochondrial membrane (part of Complex II) that catalyzes the oxidation of succinate to fumarate, which is manifested as pathological change in striatal areas of the brain. The physiological damage caused by NPA metabolic compromise resembles the genetic disorder, Huntington's disease. This resemblance has been extensively exploited in recent years to, understand the mechanisms of neurodegeneration. There are no irreversible effects resulting from ingestion of subthreshold doses of NPA, nor is there any accumulation of NPA in the body. The LD50 dose of NPA for mice and rats is between 60 and 120 mg/kg. In long-term studies, NPA did not exhibit carcinogenicity or chronic toxicity. The reported no observed adverse effect level (NOAEL) for NPA is 2.5 and 3.75 mg/kg/day for male and female rats, respectively. Results of mutagenicity tests are mixed, but positive assays can be traced back to the use of a single impure sample of NPA. Based on the NOAEL of the chronic rodent bioassay, an ADI of 25 mug/kg/day or 1.750 mg/day for a 70 kg human is appropriate. (C) 2001 Elsevier Science Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available